Medicine Press release



A Decade of Olympus India's Commitment to Community Welfare
Apr 22, 2025 12:00 JST
Olympus Medical Systems India Pvt. Ltd. (OMSI), an Olympus Group company, today announces the successful inauguration of newly constructed washrooms at eight government schools across major locations in India.
More info..


A Decade of Olympus India's Commitment to Community Welfare
Apr 22, 2025 12:00 JST
Olympus Medical Systems India Pvt. Ltd. (OMSI), an Olympus Group company, today announces the successful inauguration of newly constructed washrooms at eight government schools across major locations in India.
More info..


Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union
Apr 18, 2025 15:52 JST
Eisai Co., Ltd. and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (Aβ) monoclonal antibody Leqembi (lecanemab) Marketing Authorization (MA) in the European Union (EU).
More info..


SinoMab BioScience Limited Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis
Apr 09, 2025 14:49 JST
SinoMab BioScience Limited (Stock Code: 3681.HK, "SinoMab" or the "Company"), is pleased to announce our breakthrough topline results from the completed Phase 1b clinical study evaluating SM17, a novel investigational therapy targeting the IL-25 (IL-17E) receptor pathway in moderate to severe atopic dermatitis (AD).
More info..


NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities
Apr 01, 2025 15:15 JST
NEC Corporation has developed and successfully demonstrated a technology that enables face recognition without storing patients' facial information and ensures traceability through the entire workflow process for personalized cancer vaccine.
More info..


Eisai to Divest Rights for Pariet in China to Peak Pharma
Apr 01, 2025 12:15 JST
Eisai Co., Ltd. announced today that it has entered into an agreement to divest the rights for proton pump inhibitor Pariet (generic name: rabeprazole sodium) in China to Beijing Peak Biology Pharmaceuticals Co., Ltd., a CBC Group-controlled company.
More info..


Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024
Apr 01, 2025 01:42 JST
Cryofocus Medtech (Shanghai) Co., Ltd. ('Cryofocus Medtech' or the 'Company', stock code: 6922.HK), announced its annual results for the year ended 31 December 2024 (the 'Reporting Period').
More info..


Cryofocus Medtech: Steady Increase in Revenue and Gross Profit with Solid R&D Expenditures in 2024
Apr 01, 2025 01:42 JST
Cryofocus Medtech (Shanghai) Co., Ltd. ('Cryofocus Medtech' or the 'Company', stock code: 6922.HK), announced its annual results for the year ended 31 December 2024 (the 'Reporting Period').
More info..


Hua Medicine Announces 2024 Annual Results
Mar 28, 2025 21:51 JST
Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook.
More info..


Hua Medicine Announces 2024 Annual Results
Mar 28, 2025 21:51 JST
Hua Medicine ("the Company", Hong Kong Stock Exchange Stock Code: 2552) announced the audited full-year results of the Company and its subsidiaries for the year ended December 31, 2024 (the "Reporting Period"), along with the Company's business progress in 2024 and future business outlook.
More info..